Texas Oncology-Memorial City is a clinical research site located in Houston, Texas, United States 77024.
Crixeo Health Trust Score: 81/100 (GOOD). This profile has not yet been claimed by the site owner.
Texas Oncology-Memorial City has participated in 18 clinical trials with 1 currently active.
Therapeutic areas: Metastatic Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Sponsors: Eli Lilly and Company, Pfizer, Aeglea Biotherapeutics.
Trust Score: 81/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Texas Oncology-Memorial City has a Crixeo Trust Score of 81/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Texas Oncology-Memorial City has 18 clinical trials on record, with 1 currently active. Their work covers Metastatic Breast Cancer, Breast Neoplasms, BRCA 1 Gene Mutation.
Yes — Texas Oncology-Memorial City holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.